218 related articles for article (PubMed ID: 18211794)
1. [The use of anti-asthmatic medication among Danish elite athletes].
Lund TK; Pedersen L; Backer V
Ugeskr Laeger; 2007 Dec; 169(50):4355-9. PubMed ID: 18211794
[TBL] [Abstract][Full Text] [Related]
2. Asthma in elite athletes: how do we manage asthma-like symptoms and asthma in elite athletes?
Lund TK
Clin Respir J; 2009 Apr; 3(2):123. PubMed ID: 20298392
[TBL] [Abstract][Full Text] [Related]
3. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
Wolfarth B; Wuestenfeld JC; Kindermann W
Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical treatment of asthma symptoms in elite athletes - doping or therapy?
Backer V; Lund T; Pedersen L
Scand J Med Sci Sports; 2007 Dec; 17(6):615-22. PubMed ID: 18093034
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of asthma-like symptoms, asthma and its treatment in elite athletes.
Lund T; Pedersen L; Larsson B; Backer V
Scand J Med Sci Sports; 2009 Apr; 19(2):174-8. PubMed ID: 18282226
[TBL] [Abstract][Full Text] [Related]
6. [Utilization of anti-asthmatic drugs among Danish children in 1998].
Ingvardsen BK; Kampmann JM; Laursen LC; Johansen HL
Ugeskr Laeger; 2000 Nov; 162(45):6062-5. PubMed ID: 11107942
[TBL] [Abstract][Full Text] [Related]
7. Are the prevalence and treatment of asthma similar in elite athletes and the aged-matched non-athlete population?
Locke S; Marks G
Scand J Med Sci Sports; 2007 Dec; 17(6):623-7. PubMed ID: 17316378
[TBL] [Abstract][Full Text] [Related]
8. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
Kindermann W
Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
[TBL] [Abstract][Full Text] [Related]
9. Inhaled beta2 agonists and performance in competitive athletes.
Kindermann W; Meyer T
Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103
[TBL] [Abstract][Full Text] [Related]
10. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
11. [Long-acting beta 2-agonists in addition to inhaled corticosteroids in children and adults with chronic asthma. A survey of two Cochrane reviews].
Ulrik CS
Ugeskr Laeger; 2007 Mar; 169(11):997-1001. PubMed ID: 17371632
[No Abstract] [Full Text] [Related]
12. Asthma in elite athletes.
Elers J; Pedersen L; Backer V
Expert Rev Respir Med; 2011 Jun; 5(3):343-51. PubMed ID: 21702657
[TBL] [Abstract][Full Text] [Related]
13. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
Overbye M; Wagner U
Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
[TBL] [Abstract][Full Text] [Related]
14. Inappropriate use of inhaled short acting beta-agonists and its association with patient health status.
Hong SH; Sanders BH; West D
Curr Med Res Opin; 2006 Jan; 22(1):33-40. PubMed ID: 16393428
[TBL] [Abstract][Full Text] [Related]
15. Persistence with asthma treatment is low in Germany especially for controller medication - a population based study of 483,051 patients.
Hasford J; Uricher J; Tauscher M; Bramlage P; Virchow JC
Allergy; 2010 Mar; 65(3):347-54. PubMed ID: 19712117
[TBL] [Abstract][Full Text] [Related]
16. The asthmatic athlete: inhaled Beta-2 agonists, sport performance, and doping.
McKenzie DC; Fitch KD
Clin J Sport Med; 2011 Jan; 21(1):46-50. PubMed ID: 21200170
[TBL] [Abstract][Full Text] [Related]
17. [Interaction between inhaled corticosteroids and long-acting beta-2-agonists].
Kardos P
Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S386-9. PubMed ID: 19941242
[No Abstract] [Full Text] [Related]
18. Asthma therapy during the first 8 years of life: a PIAMA cohort study.
Zuidgeest MG; Koster ES; Maitland-van der Zee AH; Smit HA; Brunekreef B; Leufkens HG; Koppelman GH; Postma DS; de Jongste JC; Hoekstra MO;
J Asthma; 2010 Mar; 47(2):209-13. PubMed ID: 20170331
[TBL] [Abstract][Full Text] [Related]
19. [Improvement of compliance in the therapy of asthma--what about evidence and how can the effect be evaluated?].
Petro W
Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S394-7. PubMed ID: 19941244
[No Abstract] [Full Text] [Related]
20. [Do fixed ICS/LABA-combinations have advantages in terms of patient-centered parameters?].
Buhl R
Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S381-5. PubMed ID: 19941241
[No Abstract] [Full Text] [Related]
[Next] [New Search]
